Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide

CONTEXT: Diazoxide, the only U.S. Food and Drug Administration–approved drug to treat hyperinsulinemic hypoglycemia, has been associated with several adverse events, which has raised concerns about the safety of this drug. Existing reports are limited to small studies and case reports. OBJECTIVE: To...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Endocrinol Metab
Main Authors: Herrera, Adriana, Vajravelu, Mary Ellen, Givler, Stephanie, Mitteer, Lauren, Avitabile, Catherine M, Lord, Katherine, De León, Diva D
Format: Artigo
Language:Inglês
Published: Endocrine Society 2018
Subjects:
Clinical Research Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207144/
https://ncbi.nlm.nih.gov/pubmed/30247666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2018-01613
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items